drugset / Trial / NCT02136329
A Study to Determine the Pharmacokinetic Profile, Safety and Tolerability of Sildenafil (REVATIO®) in Cardiac Surgery
NaSingle-groupOpen-labelPrevention
Summary
The objectives of the study are the following: * To evaluate the pharmacokinetic profile of Sildenafil in cardiac surgery patients at risk of acute kidney injury * To determine the safety and tolerability of Sildenafil in cardiac surgery patients at risk of acute kidney injury
Timeline
- Start
- 2013-06
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sildenafil | Unknown | 10 mg | Intravenous |